CONTROLLED CLINICAL TRIALS OF DRUGS FOR USE IN PROPHYLAXIS OF MIGRAINE

被引：0
|
作者：
HUBBE, P [1 ]
机构：
[1] BISPEBJERG HOSP, DEPT NEUROL, Copenhagen, DENMARK
来源：
DANISH MEDICAL BULLETIN | 1975年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：92 / 96
页数：5
相关论文
共 50 条
  • [31] Ethical problems arising from the use of placebo in clinical trials with drugs for migraine. Their analysis by the moral deliberation method
    Frias, J.
    Pascual, J.
    Lahuerta, J.
    Gracia, D.
    Dal-Re, R.
    NEUROLOGIA, 2011, 26 (02): : 92 - 99
  • [32] PATIENT SAFETY IN CLINICAL TRIALS WITH DRUGS FOR HUMAN USE
    Casado Verdejo, Ines
    Lopez Cadenas, Cristina
    Diez Laiz, Raquel
    Postigo Mota, Salvador
    REVISTA ROL DE ENFERMERIA, 2012, 35 (06): : 442 - 445
  • [33] CONTROLLED CLINICAL-TRIALS OF PSYCHOTROPIC-DRUGS IN FRANCE
    PICHOT, P
    GUELFI, JD
    DREYFUS, JF
    PULL, CB
    DUBOISBRILLET, AM
    PSYCHIATRIC JOURNAL OF THE UNIVERSITY OF OTTAWA-REVUE DE PSYCHIATRIE DE L UNIVERSITE D OTTAWA, 1979, 4 (02): : 170 - 175
  • [34] Use of new Antibodies in Migraine Prophylaxis
    不详
    HNO, 2020, 68 (06) : 406 - 406
  • [35] Use of nefazodone in migraine prophylaxis.
    Vilchez, A
    Geronimo, M
    Yeste, MC
    Calandre, EP
    CEPHALALGIA, 1999, 19 (04) : 374 - 374
  • [36] Adherence with Migraine Prophylaxis in Clinical Practice
    Berger, Ariel
    Bloudek, Lisa M.
    Varon, Sepideh F.
    Oster, Gerry
    PAIN PRACTICE, 2012, 12 (07) : 541 - 549
  • [37] Use of new Antibodies in Migraine Prophylaxis
    不详
    HNO, 2020, 68 (04) : 271 - 271
  • [38] Clinical studies of valproate for migraine prophylaxis
    Rothrock, JF
    CEPHALALGIA, 1997, 17 (02) : 81 - 83
  • [39] Clinical trials in pediatric migraine
    Hamalainen, M.
    Winner, P.
    CEPHALALGIA, 2008, 28 (04) : 429 - 429
  • [40] Understanding clinical trials in migraine
    Tfelt-Hansen P.
    The Journal of Headache and Pain, 2006, 7 (2) : 101 - 108
12345